Sign In
Learn bits
Health & Medicine
Pradeep Kumar

09/05/21 09:20 AM IST

Anti-COVID drug developed by DRDO

In news

An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO)

About the drug
  • The drug comes in powder form in a sachet and is taken orally by dissolving it in water.
  • It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production.
  • Its selective accumulation in virally infected cells makes this drug unique.
  • Clinical trial results of the drug have shown that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
  • A higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients.
Source: PIB, The Hindu

More Related Current Affairs View All

07 Aug

What is the potential of biochar?

'With the Indian carbon market set to be launched in 2026, CO2 removal technologies such as biochar are expected to play a crucial role. ' Biochar is a type of charcoal rich in

Read More

07 Aug

Carriage of Goods by Sea Bill, 2025

'The Parliament has passed the Carriage of Goods by Sea Bill, 2025, with the Rajya Sabha approving it recently. ' The Bill seeks to replace the Indian Carriage of Goods by Sea A

Read More

07 Aug

Telangana’s Kaleshwaram project

'The Kaleshwaram Lift Irrigation Project (KLIP) in Telangana is under scrutiny after the National Dam Safety Authority (NDSA) reported significant structural damage and design flaw

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps